Volume 5 Issue 6
Nov.  2014
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2014  >  5(6): 343-347
Lu Xiaoxi, Wan Zhi, Ma Zhigui, et al. Primary graft failure following unrelated cord blood transplantation with high-dose of CD34+ cells in the treatment of AML/MDS[J]. ORGAN TRANSPLANTATION, 2014, 5(6): 343-347. doi: 10.3969/j.issn.1674-7445.2014.06.003
Citation: Lu Xiaoxi, Wan Zhi, Ma Zhigui, et al. Primary graft failure following unrelated cord blood transplantation with high-dose of CD34+ cells in the treatment of AML/MDS[J]. ORGAN TRANSPLANTATION, 2014, 5(6): 343-347. doi: 10.3969/j.issn.1674-7445.2014.06.003
shu

Primary graft failure following unrelated cord blood transplantation with high-dose of CD34+ cells in the treatment of AML/MDS

doi: 10.3969/j.issn.1674-7445.2014.06.003

  • 610041 Chengdu, Department of Pediatric Hematology and Oncology, West China Second University Hospital of Sichuan University

Funds:

National Natural Science Foundation 81000215

Technology Bureau of Chengdu 11DXYB086JH-027

More Information
  • Corresponding author: Zhu Yiping, Email:yipingzhu918@qq.com
  • Received Date: 2014-09-08
    Available Online: 2021-01-19
  • Publish Date: 2014-11-15
    Abstract
  •   Objective   To analysis the cause of primary graft failure of unrelated cord blood transplantation with high-dose of CD34+ cells in treatment of acute myelocytic leukemia(AML)/myelodysplastic syndrome (MDS[).   Methods   A 4-year-old girl was diagnosed AML/MDS at the Department of Pediatric Hematology and Oncology of West China Second University Hospital of Sichuan University. She presented completely remission after induction and consolidation chemotherapy. She received unrelated partially human leukocyte antigen(HLA)-mismatched cord blood transplantation. We investigated the treatment outcomes of UCBT and associated complications.   Results   The patient suffered primary graft failure and then received secondary haploidentical hematopoietic stem cell transplantation(HSCT) from her mother. However, she suffered fatal multiresistant Acinetobacter spp septicemia. She died due to respiratory failure on 7 d after the second transplantation.   Conclusions   In this case, hematopoietic stem cells with high dose of CD34+ cells could not overcome the risk of primary graft failure and HLA disparity. The patient's primary graft failure was associated with platelet transfusion refractoriness and potent immunologic dysfunction, especially the anti-HLA donor specific antibodies before unrelated cord blood transplantation.

     

    • FullText(HTML)
  • loading
    • References(18)
  • [1]
    Barker JN. Umbilical cord blood(UCB) transplantation: an alternative to the use of unrelated volunteer donors?[J]. Hematology Am Soc Hematol Educ Program, 2007:55-61. http://cn.bing.com/academic/profile?id=2101219010&encoded=0&v=paper_preview&mkt=zh-cn
    [2]
    Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia[J]. N Engl J Med, 2004, 351(22):2276-2285. doi: 10.1056/NEJMoa041469
    [3]
    Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients[J]. Bone Marrow Transplant, 2008, 41(2):207-214. doi: 10.1038/sj.bmt.1705963
    [4]
    Gluckman E. Hematopoietic stem-cell transplants using umbilical-cord blood[J]. N Engl J Med, 2001, 344(24):1860-1861. doi: 10.1056/NEJM200106143442410
    [5]
    Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies[J]. Blood, 2010, 115(9):1843-1849. doi: 10.1182/blood-2009-07-231068
    [6]
    Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study[J]. Lancet, 2007, 369(9577):1947-1954. doi: 10.1016/S0140-6736(07)60915-5
    [7]
    Rodrigues CA, Sanz G, Brunstein CG, et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation[J]. J Clin Oncol, 2009, 27(2):256-263. doi: 10.1200/JCO.2007.15.8865
    [8]
    Eapen M, Klein JP, Ruggeri A, et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy[J]. Blood, 2014, 123(1):133-140. doi: 10.1182/blood-2013-05-506253
    [9]
    Brunstein CG, Gutman JA, Weisdorf DJ, et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood[J]. Blood, 2010, 116(22):4693-4699. doi: 10.1182/blood-2010-05-285304
    [10]
    Urbano-Ispizua A, Carreras E, Marín P, et al. Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+)cells?[J]. Blood, 2001, 98(8):2352-2357. doi: 10.1182/blood.V98.8.2352
    [11]
    Wolff SN. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejectionor relapse after allogeneic transplantation[J]. Bone Marrow Transplant, 2002, 29(7):545-552. doi: 10.1038/sj.bmt.1703389
    [12]
    Toor AA, Choo SY, Little JA. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation[J]. Bone Marrow Transplant, 2000, 26(3):315-320. doi: 10.1038/sj.bmt.1702490
    [13]
    Komanduri KV, St John LS, de Lima M, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing[J]. Blood, 2007, 110(13):4543-4551. doi: 10.1182/blood-2007-05-092130
    [14]
    Takanashi M, Atsuta Y, Fujiwara K, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations[J]. Blood, 2010, 116(15):2839-2846. doi: 10.1182/blood-2009-10-249219
    [15]
    Ciurea SO, Thall PF, Wang X, et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation[J]. Blood, 2011, 118(22):5957-5964. doi: 10.1182/blood-2011-06-362111
    [16]
    Ciurea SO, de Lima M, Cano P, et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation[J]. Transplantation, 2009, 88(8):1019-1024. doi: 10.1097/TP.0b013e3181b9d710
    [17]
    Karanes C, Nelson GO, Chitphakdithai P, et al. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program[J]. Biol Blood Marrow Transplant, 2008, 14(9 Suppl):8-15. http://cn.bing.com/academic/profile?id=2023239299&encoded=0&v=paper_preview&mkt=zh-cn
    [18]
    Spellman S, Bray R, Rosen-Bronson S, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure[J]. Blood, 2010, 115(13):2704-2708. doi: 10.1182/blood-2009-09-244525
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (60) PDF downloads(4) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return